{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T00:16:15Z","timestamp":1773188175590,"version":"3.50.1"},"reference-count":144,"publisher":"Informa UK Limited","issue":"5-6","content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Ophthalmology"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.3109\/08820538.2014.959195","type":"journal-article","created":{"date-parts":[[2014,10,17]],"date-time":"2014-10-17T12:02:32Z","timestamp":1413547352000},"page":"263-275","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":8,"title":["Complications of Subspecialty Ophthalmic Care: Systemic Complications from the Intravitreal Administration of Agents that Target the Vascular Endothelial Growth Factor Pathway"],"prefix":"10.3109","volume":"29","author":[{"given":"David J.","family":"Ramsey","sequence":"first","affiliation":[{"name":"Harvard Medical School, Massachusetts Eye and Ear Infirmary and Massachusetts General Hospital","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luis J.","family":"Haddock","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Massachusetts Eye and Ear Infirmary and Massachusetts General Hospital","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy H.","family":"Young","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Massachusetts Eye and Ear Infirmary and Massachusetts General Hospital","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dean","family":"Eliott","sequence":"additional","affiliation":[{"name":"Harvard Medical School, Massachusetts Eye and Ear Infirmary and Massachusetts General Hospital","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2014,10,17]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2011.140"},{"key":"e_1_3_2_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0b013e3282f0ca54"},{"key":"e_1_3_2_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.07.038"},{"key":"e_1_3_2_5_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.09.006"},{"key":"e_1_3_2_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.07.026"},{"key":"e_1_3_2_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2010.12.019"},{"key":"e_1_3_2_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2010.09.004"},{"key":"e_1_3_2_9_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2007.132597"},{"key":"e_1_3_2_10_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa062655"},{"key":"e_1_3_2_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa054481"},{"key":"e_1_3_2_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.05.028"},{"key":"e_1_3_2_13_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e31821dc66f"},{"key":"e_1_3_2_14_1","doi-asserted-by":"crossref","unstructured":"Nuzzi R Tridico F. Local and systemic complications after intravitreal administration of anti-vascular endothelial growth factor agents in the treatment of different ocular diseases: a five-year retrospective study. Seminars in Ophthalmology 2013. [Epub ahead of print]","DOI":"10.3109\/08820538.2013.835833"},{"key":"e_1_3_2_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2013.107"},{"key":"e_1_3_2_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.survophthal.2010.08.006"},{"key":"e_1_3_2_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2009.06.014"},{"key":"e_1_3_2_18_1","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2415-12-37"},{"key":"e_1_3_2_19_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-011-1865-8"},{"key":"e_1_3_2_20_1","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2008.360"},{"key":"e_1_3_2_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrclinonc.2009.94"},{"key":"e_1_3_2_22_1","doi-asserted-by":"publisher","DOI":"10.1517\/14740338.5.4.553"},{"key":"e_1_3_2_23_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.6823562"},{"key":"e_1_3_2_24_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.56.4.3"},{"key":"e_1_3_2_25_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10456-006-9055-8"},{"key":"e_1_3_2_26_1","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M109.074930"},{"key":"e_1_3_2_27_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.58.061705.145635"},{"key":"e_1_3_2_28_1","doi-asserted-by":"publisher","DOI":"10.1042\/CS20040370"},{"key":"e_1_3_2_29_1","doi-asserted-by":"publisher","DOI":"10.1242\/dev.114.2.521"},{"key":"e_1_3_2_30_1","doi-asserted-by":"publisher","DOI":"10.1038\/380435a0"},{"key":"e_1_3_2_31_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.19.8915"},{"key":"e_1_3_2_32_1","doi-asserted-by":"publisher","DOI":"10.1242\/dev.125.4.725"},{"key":"e_1_3_2_33_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.276.5317.1423"},{"key":"e_1_3_2_34_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.282.5390.946"},{"key":"e_1_3_2_35_1","doi-asserted-by":"publisher","DOI":"10.1038\/376062a0"},{"key":"e_1_3_2_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms1977"},{"key":"e_1_3_2_37_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2008.04.023"},{"key":"e_1_3_2_38_1","first-page":"353","article-title":"Vascular endothelial growth factor localization in human ovary and fallopian tubes: possible role in reproductive function and ovarian cyst formation","volume":"81","author":"Gordon JD","year":"1996","unstructured":"Gordon JD, Mesiano S, Zaloudek CJ, Jaffe RB. Vascular endothelial growth factor localization in human ovary and fallopian tubes: possible role in reproductive function and ovarian cyst formation. J Clin Endocrinol Meta 1996;81:353\u2013359","journal-title":"J Clin Endocrinol Meta"},{"key":"e_1_3_2_39_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tem.2012.05.006"},{"key":"e_1_3_2_40_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00109-011-0739-1"},{"key":"e_1_3_2_41_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.182296499"},{"key":"e_1_3_2_42_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.97.18.10242"},{"key":"e_1_3_2_43_1","first-page":"31","article-title":"The neuroprotective function of vascular endothelial growth factor (VEGF)","volume":"43","author":"Gora-Kupilas K","year":"2005","unstructured":"Gora-Kupilas K, Josko J. The neuroprotective function of vascular endothelial growth factor (VEGF). Folia neuropathologica\/Assoc of Polish Neuropathol and Med Res Cen, Polish Acad of Sci 2005;43:31\u201339","journal-title":"Folia neuropathologica\/Assoc of Polish Neuropathol and Med Res Cen, Polish Acad of Sci"},{"key":"e_1_3_2_44_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0003554"},{"key":"e_1_3_2_45_1","doi-asserted-by":"publisher","DOI":"10.2353\/ajpath.2007.061237"},{"key":"e_1_3_2_46_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2010.07.011"},{"key":"e_1_3_2_47_1","doi-asserted-by":"publisher","DOI":"10.1053\/sonc.2002.37264"},{"key":"e_1_3_2_48_1","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.13.1.9"},{"key":"e_1_3_2_49_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa042760"},{"key":"e_1_3_2_50_1","first-page":"2408","article-title":"VEGF-initiated blood-retinal barrier breakdown in early diabetes","volume":"42","author":"Qaum T","year":"2001","unstructured":"Qaum T, Xu Q, Joussen AM, et al. VEGF-initiated blood-retinal barrier breakdown in early diabetes. Invest Ophthalmol Vis Sci 2001;42:2408\u20132413","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"e_1_3_2_51_1","doi-asserted-by":"publisher","DOI":"10.1586\/17512433.2014.884458"},{"key":"e_1_3_2_52_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1007657109012"},{"key":"e_1_3_2_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2007.02.021"},{"key":"e_1_3_2_54_1","volume-title":"U.S. Full Prescribing Information","author":"Macugen (pegaptanib) [package insert]","year":"2008","unstructured":"Macugen (pegaptanib) [package insert]. U.S. Full Prescribing Information; Cedar Knolls, NJ: Eyetech Inc., 2008"},{"key":"e_1_3_2_55_1","volume-title":"U.S. Full Prescribing Information","author":"Lucentis (ranibizumab) [package insert]","year":"2014","unstructured":"Lucentis (ranibizumab) [package insert]. U.S. Full Prescribing Information; South San Francisco, CA: Genentech, Inc., 2014"},{"key":"e_1_3_2_56_1","doi-asserted-by":"publisher","DOI":"10.1177\/019262339902700507"},{"key":"e_1_3_2_57_1","unstructured":"Xu L JN Eppler S Lu J Damico L Joshi A. Population pharmacokinetics of ranibizumab in patients with age-related macular degeneration. American Association of Pharmaceutical Scientists meeting. San Antonio TX 29 October--2 November 2006"},{"key":"e_1_3_2_58_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2012.03.047"},{"key":"e_1_3_2_59_1","doi-asserted-by":"publisher","DOI":"10.1177\/107327480200900207"},{"key":"e_1_3_2_60_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.iae.0000242842.14624.e7"},{"key":"e_1_3_2_61_1","volume-title":"U.S. Full Prescribing Information","author":"Eylea (afilbercept) [package insert]","year":"2014","unstructured":"Eylea (afilbercept) [package insert]. U.S. Full Prescribing Information; Tarrytown, NY: Regeneron, Inc., 2014"},{"key":"e_1_3_2_62_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10456-011-9249-6"},{"key":"e_1_3_2_63_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2012.04.020"},{"key":"e_1_3_2_64_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2011-300654"},{"key":"e_1_3_2_65_1","volume-title":"U.S. Full Prescribing Information","author":"Avastin(bevacizumab) [package insert]","year":"2013","unstructured":"Avastin(bevacizumab) [package insert]. U.S. Full Prescribing Information; South San Francisco, CA: Genentech, Inc., 2013"},{"key":"e_1_3_2_66_1","doi-asserted-by":"publisher","DOI":"10.3928\/1542-8877-20050701-14"},{"key":"e_1_3_2_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.04.015"},{"key":"e_1_3_2_68_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2012.03.053"},{"key":"e_1_3_2_69_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1102673"},{"key":"e_1_3_2_70_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2009.178574"},{"key":"e_1_3_2_71_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e318217373c"},{"key":"e_1_3_2_72_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00417-010-1315-z"},{"key":"e_1_3_2_73_1","first-page":"CD007920","article-title":"Anti-vascular endothelial growth factor for neovascular glaucoma","volume":"10","author":"Simha A","year":"2013","unstructured":"Simha A, Braganza A, Abraham L, et al. Anti-vascular endothelial growth factor for neovascular glaucoma. Cochrane Database Sys Rev 2013;10:CD007920","journal-title":"Cochrane Database Sys Rev"},{"key":"e_1_3_2_74_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1007374"},{"key":"e_1_3_2_75_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2403"},{"key":"e_1_3_2_76_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrd1955"},{"key":"e_1_3_2_77_1","doi-asserted-by":"publisher","DOI":"10.1097\/ICU.0b013e32832d25b3"},{"key":"e_1_3_2_78_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.13-13054"},{"key":"e_1_3_2_79_1","doi-asserted-by":"publisher","DOI":"10.3109\/02713683.2013.763988"},{"key":"e_1_3_2_80_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.12-10164"},{"key":"e_1_3_2_81_1","doi-asserted-by":"publisher","DOI":"10.1097\/01.iae.0000233327.68433.02"},{"key":"e_1_3_2_82_1","doi-asserted-by":"publisher","DOI":"10.1038\/nm.3407"},{"key":"e_1_3_2_83_1","doi-asserted-by":"publisher","DOI":"10.1159\/000315617"},{"key":"e_1_3_2_84_1","doi-asserted-by":"publisher","DOI":"10.1016\/0039-6257(82)90081-9"},{"key":"e_1_3_2_85_1","doi-asserted-by":"publisher","DOI":"10.5301\/ejo.5000118"},{"key":"e_1_3_2_86_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e3181e46ad8"},{"key":"e_1_3_2_87_1","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2008.156810"},{"key":"e_1_3_2_88_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.2011.02240.x"},{"key":"e_1_3_2_89_1","doi-asserted-by":"crossref","unstructured":"Avery RL. What is the evidence for systemic effects of intravitreal anti-VEGF agents and should we be concerned? Br J Ophthalmol 2013;98(Suppl 1):i7--i10","DOI":"10.1136\/bjophthalmol-2013-303844"},{"key":"e_1_3_2_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2006.05.064"},{"key":"e_1_3_2_91_1","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2008.162"},{"key":"e_1_3_2_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2011.07.005"},{"key":"e_1_3_2_93_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.2009.01842.x"},{"key":"e_1_3_2_94_1","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.09-4140"},{"key":"e_1_3_2_95_1","doi-asserted-by":"publisher","DOI":"10.3341\/kjo.2014.28.1.32"},{"key":"e_1_3_2_96_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e318186c64e"},{"key":"e_1_3_2_97_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.2009.01773.x"},{"key":"e_1_3_2_98_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2011.04.014"},{"key":"e_1_3_2_99_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0042701"},{"key":"e_1_3_2_100_1","first-page":"CD005139","article-title":"Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related macular degeneration","volume":"2","author":"Vedula SS","year":"2008","unstructured":"Vedula SS, Krzystolik MG. Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for neovascular age-related macular degeneration. Cochrane Database Syst Rev 2008;2:CD005139","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_2_101_1","first-page":"CD007325","article-title":"Anti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusion","volume":"5","author":"Braithwaite T","year":"2014","unstructured":"Braithwaite T, Nanji AA, Lindsley K, Greenberg PB. Anti-vascular endothelial growth factor for macular oedema secondary to central retinal vein occlusion. Cochrane Database Syst Rev 2014;5:CD007325","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_2_102_1","first-page":"CD009510","article-title":"Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion","volume":"1","author":"Mitry D","year":"2013","unstructured":"Mitry D, Bunce C, Charteris D. Anti-vascular endothelial growth factor for macular oedema secondary to branch retinal vein occlusion. Cochrane Database Syst Rev 2013;1:CD009510","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_2_103_1","first-page":"CD007419","article-title":"Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema","volume":"12","author":"Virgili G","year":"2012","unstructured":"Virgili G, Parravano M, Menchini F, Brunetti M. Antiangiogenic therapy with anti-vascular endothelial growth factor modalities for diabetic macular oedema. Cochrane Database Syst Rev 2012;12:CD007419","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_2_104_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11523-009-0106-0"},{"key":"e_1_3_2_105_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djm086"},{"key":"e_1_3_2_106_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.10.066"},{"key":"e_1_3_2_107_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.1612"},{"key":"e_1_3_2_108_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11906-009-0082-x"},{"key":"e_1_3_2_109_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc063011"},{"key":"e_1_3_2_110_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e3182695ba0"},{"key":"e_1_3_2_111_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.2011.02117.x"},{"key":"e_1_3_2_112_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2013.02.019"},{"key":"e_1_3_2_113_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2006.05.055"},{"key":"e_1_3_2_114_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2013.08.011"},{"key":"e_1_3_2_115_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.sjopt.2012.02.005"},{"key":"e_1_3_2_116_1","doi-asserted-by":"publisher","DOI":"10.5301\/EJO.2010.5819"},{"key":"e_1_3_2_117_1","unstructured":"Barron H. Genentech: important drug warning (letter); South San Francisco CA: US Food and Drug Administration: MedWatch 2005"},{"key":"e_1_3_2_118_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2009.05.024"},{"key":"e_1_3_2_119_1","unstructured":"Barron H. Genentech: important drug warning (letter); South San Francisco CA: US Food and Drug Administration: MedWatch 2007"},{"key":"e_1_3_2_120_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e31825db6ba"},{"key":"e_1_3_2_121_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2008.09.046"},{"key":"e_1_3_2_122_1","doi-asserted-by":"publisher","DOI":"10.1001\/archophthalmol.2010.223"},{"key":"e_1_3_2_123_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.e4203"},{"key":"e_1_3_2_124_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejca.2009.11.001"},{"key":"e_1_3_2_125_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa072113"},{"key":"e_1_3_2_126_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa061884"},{"key":"e_1_3_2_127_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(07)61904-7"},{"key":"e_1_3_2_128_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0707330"},{"key":"e_1_3_2_129_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfl565"},{"key":"e_1_3_2_130_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdm454"},{"key":"e_1_3_2_131_1","doi-asserted-by":"crossref","unstructured":"Georgalas I Papaconstantinou D Papadopoulos K et al. Renal injury following intravitreal anti-VEGF administration in diabetic patients with proliferative diabetic retinopathy and chronic kidney disease: a possible side effect? Current Drug Safety 2014. [Epub ahead of print]","DOI":"10.2174\/1574886309666140211113635"},{"key":"e_1_3_2_132_1","first-page":"127","article-title":"Complications of intravitreal injections\u2013own experience","volume":"113","author":"Jamrozy-Witkowska A","year":"2011","unstructured":"Jamrozy-Witkowska A, Kowalska K, Jankowska-Lech I, et al. Complications of intravitreal injections\u2013own experience. Klinika Oczna 2011;113:127\u2013131","journal-title":"Klinika Oczna"},{"key":"e_1_3_2_133_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2007.05.062"},{"key":"e_1_3_2_134_1","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2010.11.030"},{"key":"e_1_3_2_135_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2006.10.007"},{"key":"e_1_3_2_136_1","doi-asserted-by":"publisher","DOI":"10.3109\/15569527.2011.609207"},{"key":"e_1_3_2_137_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-3768.2009.01572.x"},{"key":"e_1_3_2_138_1","doi-asserted-by":"publisher","DOI":"10.1097\/IAE.0b013e3181f57d58"},{"key":"e_1_3_2_139_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2012.0067"},{"key":"e_1_3_2_140_1","doi-asserted-by":"publisher","DOI":"10.1038\/eye.2013.311"},{"key":"e_1_3_2_141_1","first-page":"2","article-title":"Bevacizumab-mediated interference with VEGF signaling is sufficient to induce a preeclampsia-like syndrome in nonpregnant women","volume":"5","author":"Cross SN","year":"2012","unstructured":"Cross SN, Ratner E, Rutherford TJ, et al. Bevacizumab-mediated interference with VEGF signaling is sufficient to induce a preeclampsia-like syndrome in nonpregnant women. Rev Obstet Gynecol 2012;5:2\u20138","journal-title":"Rev Obstet Gynecol"},{"key":"e_1_3_2_142_1","doi-asserted-by":"publisher","DOI":"10.1093\/jb\/mvs136"},{"key":"e_1_3_2_143_1","doi-asserted-by":"publisher","DOI":"10.4103\/0974-9233.65497"},{"key":"e_1_3_2_144_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2006.08.003"},{"key":"e_1_3_2_145_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2011.51"}],"container-title":["Seminars in Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.3109\/08820538.2014.959195","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T12:17:58Z","timestamp":1753100278000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.3109\/08820538.2014.959195"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9]]},"references-count":144,"journal-issue":{"issue":"5-6","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["10.3109\/08820538.2014.959195"],"URL":"https:\/\/doi.org\/10.3109\/08820538.2014.959195","relation":{},"ISSN":["0882-0538","1744-5205"],"issn-type":[{"value":"0882-0538","type":"print"},{"value":"1744-5205","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=isio20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=isio20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2014-05-19","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-07-26","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-08-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-10-17","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}